Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov;104(11):1488-1491.
doi: 10.1136/bjophthalmol-2019-314583. Epub 2020 Feb 18.

Optic disc haemorrhage and primary open-angle glaucoma: a clinical review

Affiliations
Review

Optic disc haemorrhage and primary open-angle glaucoma: a clinical review

Uma Jasty et al. Br J Ophthalmol. 2020 Nov.

Abstract

Studies have confirmed that optic disc haemorrhage (ODH) is a significant risk factor for the development and progression of primary open-angle glaucoma (POAG). Various populations have differing risk factors for developing POAG. As such, a literature review was conducted examining seven studies published in India, China, Japan, Australia, Korea and the USA. The goal of this review was to better identify ODH risk factors and their relationship to development and progression of POAG. Ultimately, patients with ODH have a greater risk for developing POAG across all populations analysed in this review. However, some populations demonstrated additional risk factors for ODH, such as increasing age and female gender. Paradoxically, data from several studies show that people of African descent have a reduced risk of ODH despite having increased risk of open-angle glaucoma than their Caucasian counterparts. By parsing out the complex relations between ODH and open-angle glaucoma stratified by age, gender and race, we may gain a broader understanding of glaucoma pathogenesis and derive individualised treatment strategies.

Keywords: glaucoma; optic nerve; retina.

PubMed Disclaimer

Conflict of interest statement

Competing interests: AH would like to disclose that he receives remuneration from AdOM for serving as a consultant and a board member, and from Thea for a speaking engagement. AH also holds an ownership interest in AdOM, Luseed, Oxymap and QuLent. LRP would like to disclose that he on the advisory Boards for Eyenovia, Emerald Bioscience, Nicox and Bausch + Lomb. He also consults for Verily.

Publication types